Pittsburgh – September 28, 2026 -- Allegheny Health Network (AHN) has secured a $1 million commitment from Greg and Ellen Jordan to fund the Greg and Ellen Jordan Endowed Professorship for Alzheimer's Disease and Related Disorders within its Department of Neurology.
Jordan gift targets research, education and expanded memory disorder care
The endowment will fund clinical care, neuroscience research and support programming for patients with Alzheimer's disease, dementia and cognitive impairment. Greg Jordan is chairman of the Board of Directors of Highmark Health since 2025, sits on the board of MSA Safety, and serves as vice chairman of PNC after retiring as PNC's general counsel and chief administrative officer in 2024.
"We have each lost a parent to memory-related diseases, and we know that supporting AHN's research in this field is needed to continue to make progress on finding ways to deal with these challenges," Jordan said.
Memory Disorders Clinic at West Penn Hospital serves 2,000 patients annually
The gift will fund enhancements to AHN's Memory Disorders Clinic at West Penn Hospital, which currently treats approximately 2,000 patients a year through a model addressing neurological needs, caregiver demands, behavioral health, social determinants of health and advance-care planning. Space upgrades will create an environment where memory neurologists, nurse navigators, geriatricians, pharmacists and dietitians can collaborate on diagnosis and treatment.
Clinic expansion links to new five-story AHN Neuroscience hub at Allegheny General Hospital
The West Penn clinic's growth is part of a broader network strategy anchored by a new five-story neuroscience hub at Allegheny General Hospital, designed to coordinate care, diagnostics, therapies, research and education across AHN's neurological service lines. AHN has also launched the Aging Brain Care Program for caregiver coaching and participates in the CMS Guiding an Improved Dementia Experience (GUIDE) model.
US dementia cases projected to hit 8.5 million by 2030, 14 million by 2060
The number of Americans living with Alzheimer's disease and related dementias is projected to reach 8.5 million by 2030 and 14 million by 2060, according to the release. "Investments like this are essential to advancing our mission of providing remarkable health care experiences for patients and families throughout Western Pennsylvania," said Mark Sevco, president of AHN. Stephen Samples, MD, chair of AHN's Department of Neurology, said the funding will support both patient care and research advancement. AHN and parent Highmark Health frame the investment as reinforcing their "Living Health" model, which emphasizes prevention and early detection across physical, mental and social health.